I think the biggest challenge is not meeting the s

I think the biggest challenge is not meeting the sp to uplist, but to generate the supply to meet the demand. Not to get too far ahead of ourselves, but if this plays out well for the patients over the next couple of weeks, NP's biggest challenge will be to spin up the needed supply. I suspect NP is already working with the suppliers (i.e. Samsung and the other supplier which I can't recall their name).

My comments are just my opinions and should NOT be taken as investment advice.